FYU-981（最終製剤）の臨床薬理

基本情報

NCT ID: NCT03350373
ステータス: 完了
試験のフェーズ: 第1相
試験タイプ: 介入
目標被験者数: 12
治験依頼者名: Mochida Pharmaceutical Company, Ltd.

概要

This is a randomized, open-label, 2-period crossover study. The purpose of this study is to assess the pharmacokinetics and safety after single oral administration of final formulation of FYU-981 to healthy male adults in fasted and fed conditions. Participants are randomized to fasted (n=6) or fed conditions (n=6) in each step. The effect of food to pharmacokinetics of FYU-981 is also investigated.

対象疾患

Healthy

介入

FYU-981(DRUG)

依頼者（Sponsor）

株式会社富士薬品 (INDUSTRY)

Mochida Pharmaceutical Company(INDUSTRY)

実施施設 (1)

P-One Clinic

Hachiōji, Tokyo, Japan